학술논문
Abemaciclib plus endocrine therapy for HR+, HER2-, node-positive, high-risk early breast cancer: results from a pre-planned monarchE overall survival interim analysis, including 4-year efficacy outcomes
Document Type
Journal
Author
Johnston, Stephen; Toi, Masakazu; O'Shaughnessy, Joyce; Rastogi, Priya; Campone, Mario; Neven, Patrick; Huang, Chiun Sheng; Huober, Jens; Jaliffe, Georgina Garnica; Cicin, Irfan; Tolaney, Sara; Goetz, Matthew P.; Rugo, Hope; Senkus, Elzbieta; Testa, Laura; Del Mastro, Lucia; Shimizu, Chikako; Wei, Ran; Shahir, Ashwin; Munoz, Maria; Antonio, Belen San; Andre, Valerie; Harbeck, Nadia; Martin, Miguel
Source
Subject
Language
English
ISSN
15387445